PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

Increase in the dosage of cellular oncogenes by DNA amplification is a frequent genetic alteration of cancer cells. In neuroblastoma, amplification of the gene MYCN has been associated with aggressively growing cancers and is an indicator for poor prognosis. MYCN amplification is of predictive value in identifying patients with neuroblastoma who require specific therapeutic regimens and those who do not benefit from chemotherapy.

[1]  S. Akira,et al.  Activation and regulation of Toll-like receptors 2 and 1 in human leprosy , 2003, Nature Medicine.

[2]  D. Raoult,et al.  Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever. , 2003, The Journal of infectious diseases.

[3]  S. Akira,et al.  Toll receptors and pathogen resistance , 2003, Cellular microbiology.

[4]  Hans G. Baumann,et al.  Infektionsschutzgesetz : Kommentar und Vorschriftensammlung , 2003 .

[5]  Joel V Weinstock,et al.  Granulomas in schistosome and mycobacterial infections: a model of local immune responses. , 2003, Trends in immunology.

[6]  M. Aepfelbacher,et al.  Yersinia V–Antigen Exploits Toll-like Receptor 2 and CD14 for Interleukin 10–mediated Immunosuppression , 2002, The Journal of experimental medicine.

[7]  M. Koopmans,et al.  Human caliciviruses in Europe. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  S. Antinori,et al.  Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  M. Schwab,et al.  Functional interaction of Yaf2 with the central region of MycN , 2001, Oncogene.

[10]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[11]  M. Schwab,et al.  Amplification of oncogenes revisited: from expression profiling to clinical application. , 2001, Cancer letters.

[12]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[13]  D. Raoult,et al.  Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. , 2001, The New England journal of medicine.

[14]  M Schwab,et al.  N‐myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis , 2001, The EMBO journal.

[15]  M. Schwab,et al.  DAP-5 is involved in MycN/IFNγ-induced apoptosis in human neuroblastoma cells , 2001 .

[16]  A CATALOGUE OF QUASARS AND ACTIVE NUCLEI , 2001 .

[17]  R. Böni,et al.  [Helicobacter pylori and skin diseases--a (still) intact myth?]. , 2000, Schweizerische medizinische Wochenschrift.

[18]  M. Estes,et al.  Taxonomy of the caliciviruses. , 2000, The Journal of infectious diseases.

[19]  M. Schwab,et al.  MycN sensitizes neuroblastoma cells for drug-induced apoptosis , 1999, Oncogene.

[20]  M. Schwab,et al.  MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells , 1998, Oncogene.

[21]  H. Vaudry,et al.  Characterization and localization of two forms of gonadotropin-releasing hormone (GnRH) in the spinal cord of the frog Rana ridibunda , 1998, Cell and Tissue Research.

[22]  H. Stein,et al.  MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[23]  Y. Kim,et al.  Identification and characterization of the MUC2 (human intestinal mucin) gene 5'-flanking region: promoter activity in cultured cells. , 1997, The Biochemical journal.

[24]  C. Orfanos,et al.  [Detection of Helicobacter pylori in dermatoses. Clinical incidental finding or pathogenetic association?]. , 1996, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[25]  H. Stein,et al.  Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. , 1996, Cancer letters.

[26]  P. Verhaert,et al.  Insect neuropeptide F (NPF)-related peptides: isolation from Colorado potato beetle (Leptinotarsa decemlineata) brain. , 1996, Insect biochemistry and molecular biology.

[27]  J. Benson,et al.  The GABAA receptors. From subunits to diverse functions. , 1996, Ion channels.

[28]  C. Hanski.  Is mucinous carcinoma of the colorectum a distinct genetic entity? , 1995, British Journal of Cancer.

[29]  S. Russek,et al.  From ion currents to genomic analysis: Recent advances in GABAA receptor research , 1995, Synapse.

[30]  H. Deeg,et al.  Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts. , 1995, Transplantation.

[31]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[32]  S. Weitzman,et al.  Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. , 1995, Oncogene.

[33]  M. Schwab,et al.  Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. , 1995, Oncogene.

[34]  I. Christensen,et al.  Flow cytometric DNA ploidy defines patients with poor prognosis in node‐negative breast cancer , 2007, International Journal of Cancer.

[35]  R. Macdonald,et al.  Protein kinase C enhances recombinant bovine α1β1γ2L GABAA receptor whole-cell currents expressed in L929 fibroblasts , 1994, Neuron.

[36]  H. Stein,et al.  Expression of MUC2‐mucin in colorectal adenomas and carcinomas of different histological types , 1994, International journal of cancer.

[37]  F. Speleman,et al.  Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. , 1994, American journal of human genetics.

[38]  M. Schwab,et al.  Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. , 1994, American journal of human genetics.

[39]  G. Thomas,et al.  Two distinct deleted regions on the short arm of chromosome I in neuroblastoma , 1994, Genes, chromosomes & cancer.

[40]  S. Moss,et al.  Differential phosphorylation of intracellular domains of gamma-aminobutyric acid type A receptor subunits by calcium/calmodulin type 2-dependent protein kinase and cGMP-dependent protein kinase. , 1994, The Journal of biological chemistry.

[41]  M. Schwab,et al.  MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Slamon,et al.  Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. , 1994, Cancer research.

[43]  R. Huganir,et al.  Regulation of GABAA receptor function by protein kinase C phosphorylation , 1994, Neuron.

[44]  M. Schwab,et al.  There may be two tumor suppressor genes on chromosome arm Ip closely associated with biologically distinct subtypes of neuroblastoma , 1994, Genes, chromosomes & cancer.

[45]  A. Fasolo,et al.  Multiple sources of the pituitary pars intermedia innervation in amphibians: A DiI retrograde tract-tracing study , 1994, Neuroscience Letters.

[46]  L. Skoog,et al.  Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer. , 1994, Acta oncologica.

[47]  F Nistal de Paz,et al.  [Q fever]. , 1994, Medicina clinica.

[48]  R. Olsen,et al.  GABAA receptor channels. , 1994, Annual review of neuroscience.

[49]  M. Miwa,et al.  Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. , 1994, Cancer research.

[50]  M. Schwab,et al.  Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RB1. , 1993, Oncogene.

[51]  S. Baylin,et al.  Increased cytosine DNA-methyltransferase activity during colon cancer progression. , 1993, Journal of the National Cancer Institute.

[52]  M. Browning,et al.  Ca2+/Calmodulin‐Dependent Protein Kinase II and Protein Kinase C Phosphorylate a Synthetic Peptide Corresponding to a Sequence That Is Specific for the γ2L Subunit of the GABAA Receptor , 1993, Journal of neurochemistry.

[53]  D. Israel.  A PCR-based method for high stringency screening of DNA libraries. , 1993, Nucleic acids research.

[54]  Rogier Versteeg,et al.  Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N–myc amplification , 1993, Nature Genetics.

[55]  Anna Naumova,et al.  Preferential amplification of the paternal allele of the N–myc gene in human neuroblastomas , 1993, Nature Genetics.

[56]  H. Vaudry,et al.  Multihormonal Regulation of Pituitary Melanotrophs a , 1993, Annals of the New York Academy of Sciences.

[57]  H. Vaudry,et al.  Analysis of Inositol Phosphate Metabolism in Melanotrope Cells of Xenopus laevis in Relation to Background Adaptation a , 1993, Annals of the New York Academy of Sciences.

[58]  H. Vaudry,et al.  Two molecular forms of gonadotropin-releasing hormone from the brain of the frog, Rana ribibunda: purification, characterization, and distribution. , 1993, Endocrinology.

[59]  H. Deeg,et al.  What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease? , 1993, Transplantation.

[60]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[61]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[62]  G R Stark,et al.  Regulation and mechanisms of mammalian gene amplification. , 1993, Advances in cancer research.

[63]  Iver Petersen,et al.  Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system , 1993, Molecular carcinogenesis.

[64]  E. Zackai,et al.  Constitutional 1p36 deletion in a child with neuroblastoma. , 1993, American journal of human genetics.

[65]  Pepe,et al.  Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. , 1993, Blood.

[66]  S. Chakrabarty,et al.  Proliferation of human colon cancer cells: Role of epidermal growth factor and transforming growth factorα , 1992, International journal of cancer.

[67]  A. Perkins,et al.  Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. , 1992, Genes & development.

[68]  H. Deeg,et al.  PHARMACOLOGIC, TOXICOLOGIC, AND MARROW TRANSPLANTATION STUDIES IN DOGS GIVEN SUCCINYL ACETONE , 1992, Transplantation.

[69]  D. Raoult,et al.  African tick-bite fever: a new spotted fever group rickettsiosis under an old name , 1992, The Lancet.

[70]  H. Deeg,et al.  Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia [letter] , 1992 .

[71]  O. Bosler,et al.  Co‐localization of tyrosine hydroxylase, GABA and neuropeptide Y within axon terminals innervating the intermediate lobe of the frog Rana ridibunda , 1992, The Journal of comparative neurology.

[72]  G. Fuller,et al.  Amplified cellular oncogenes in neoplasms of the human central nervous system. , 1992, Mutation research.

[73]  P Boracchi,et al.  Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  D. Birnbaum,et al.  DNA amplification at 11q13 in human cancer: from complexity to perplexity. , 1992, Mutation research.

[75]  K. Alitalo,et al.  Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation , 1992, Science.

[76]  M. Schwab,et al.  Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA. , 1992, Oncogene.

[77]  N. Akaike,et al.  Direct modulation of GABAA receptor by intracellular ATP in dissociated nucleus tractus solitarii neurones of rat. , 1992, The Journal of physiology.

[78]  J. Foekens,et al.  Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. , 1992, European journal of cancer.

[79]  M. Schwab,et al.  Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. , 1992, Oncogene.

[80]  M. Fernö,et al.  Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. , 1992, Acta oncologica.

[81]  D. Burt,et al.  GABAA receptor subtypes: from pharmacology to molecular biology , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  M. Schwab,et al.  The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367. , 1991, Oncogene.

[83]  R. Silvestrini.  Feasibility and reproducibility of the [3H]‐thymidine labelling index in breast cancer , 1991, Cell proliferation.

[84]  E. Wagner,et al.  Localization of regulatory elements controlling human MYCN expression. , 1991, Oncogene.

[85]  A. Kashlinsky,et al.  Large-scale structure in the Universe , 1991, Nature.

[86]  G. Wahl,et al.  A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. , 1991, Genes & development.

[87]  F. Lampariello,et al.  Comparison of gaussian and t-distribution densities for modeling fluorescence dispersion in flow cytometric DNA histograms. , 1991, Cytometry.

[88]  M. Fernö,et al.  ERBB2 amplification in breast cancer with a high rate of proliferation. , 1991, Oncogene.

[89]  M. Schwab.  Is there a neuroblastoma anti-oncogene? , 1991, Progress in clinical and biological research.

[90]  T. Visakorpi,et al.  Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. , 1991, Cytometry.

[91]  R. Eisenman,et al.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.

[92]  N. Porter,et al.  Cyclic AMP-dependent protein kinase decreases GABAA receptor current in mouse spinal neurons , 1990, Neuron.

[93]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[94]  R. Storb,et al.  Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. , 1990, Human immunology.

[95]  F. Speleman,et al.  Constitutional translocation t(1;17)(p36;q12–21) in a patient with neuroblastoma , 1990, Genes, chromosomes & cancer.

[96]  V L Roggli,et al.  Human disease consequences of fiber exposures: a review of human lung pathology and fiber burden data. , 1990, Environmental health perspectives.

[97]  M. Schwab,et al.  Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity. , 1990, Cancer research.

[98]  R. Olsen,et al.  Molecular biology of GABAA receptors , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  C R King,et al.  Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  A. Draguhn,et al.  Sequence and expression of a novel GABAA receptor α subunit , 1989 .

[101]  M. Schwab,et al.  Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA , 1989, Molecular and cellular biology.

[102]  As.  Non-occupational Exposure to Mineral Fibres , 1989, IARC scientific publications.

[103]  M. Schwab,et al.  Suppression of MYC by high expression of NMYC in human neuroblastoma cells , 1989, Journal of neuroscience research.

[104]  S. Koscielny,et al.  Growth rate, kinetics of tumor cell proliferation and long‐term outcome in human breast cancer , 1989, International journal of cancer.

[105]  H. Deeg,et al.  Use of trimetrexate for the prevention of graft-versus-host disease. , 1989, Bone marrow transplantation.

[106]  N C Dracopoli,et al.  Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[107]  P. Seeburg,et al.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology , 1989, Nature.

[108]  K. Alitalo,et al.  Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene , 1989, Molecular and cellular biology.

[109]  K. Sullivan,et al.  Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. , 1989, The New England journal of medicine.

[110]  G M Clark,et al.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.

[111]  A. W. Harris,et al.  N‐myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross‐regulation with c‐myc. , 1989, The EMBO journal.

[112]  M. Lohuizen,et al.  N‐myc is frequently activated by proviral insertion in MuLV‐induced T cell lymphomas. , 1989, The EMBO journal.

[113]  Davis Jm.  Mineral fibre carcinogenesis: experimental data relating to the importance of fibre type, size, deposition, dissolution and migration. , 1989 .

[114]  M. Roller,et al.  Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. , 1989, IARC scientific publications.

[115]  J. Hablitz,et al.  cAMP increases the rate of GABAA receptor desensitization in chick cortical neurons , 1989, Synapse.

[116]  M. Schwab,et al.  Chromosome 1 deletions in human neuroblastomas: generation and fine mapping of microclones from the distal 1p region. , 1989, Genes, chromosomes & cancer.

[117]  M. Farrant,et al.  "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation. , 1988, Molecular pharmacology.

[118]  J. Bishop,et al.  Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[119]  J. M. Davis,et al.  Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. , 1988, British journal of experimental pathology.

[120]  H. Vaudry,et al.  NPY-like peptides occur in the nervous system and midgut of the migratory locust, Locusta migratoria and in the brain of the grey fleshfly, Sarcophaga bullata , 1988, Peptides.

[121]  R. Wong,et al.  GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors. , 1988, Science.

[122]  M. Lippmann.  Asbestos exposure indices. , 1988, Environmental research.

[123]  R. Silvestrini,et al.  Comparative Analysis of Different Approaches to Investigate Cell Kinetics , 1988, Cell and tissue kinetics.

[124]  Günter Oberdörster,et al.  Lung Clearance of Inhaled Insoluble and Soluble Particles , 1988 .

[125]  M. Israel,et al.  Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. , 1988, Experimental cell biology.

[126]  J. Wagner,et al.  Experimental studies with palygorskite dusts. , 1987, British journal of industrial medicine.

[127]  R. Gelber,et al.  Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. , 1987, Cancer research.

[128]  C. P. Yu,et al.  Predictive models for deposition of inhaled diesel exhaust particles in humans and laboratory species. , 1987, Research report.

[129]  M. Schwab,et al.  Expression of N-myc and c-src during the development of fetal human brain. , 1987, Cancer research.

[130]  M. Schwab,et al.  Neoplastic transformation by the human gene N-myc , 1987, Molecular and cellular biology.

[131]  F. Pott.  Problems in defining carcinogenic fibres. , 1987, The Annals of occupational hygiene.

[132]  F. Huth,et al.  Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. , 1987, Experimental pathology.

[133]  K. Spurny,et al.  Persistence of man-made mineral fibres (MMMF) and asbestos in rat lungs. , 1987, The Annals of occupational hygiene.

[134]  S. Takenaka,et al.  Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. , 1987, The Annals of occupational hygiene.

[135]  L. W. Ortiz,et al.  Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres. , 1987, The Annals of occupational hygiene.

[136]  L. Cazin,et al.  GABA-ergic control of α-Melanocyte-Stimulating Hormone (α-MSH) release by frog neurointermediate lobe in vitro , 1986, Brain Research Bulletin.

[137]  H. Deeg,et al.  Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow. , 1986, Bone marrow transplantation.

[138]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.

[139]  J Addison,et al.  The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. , 1986, British journal of experimental pathology.

[140]  M. Schwab,et al.  Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome. , 1986, Cancer research.

[141]  B. Kushner,et al.  Familial neuroblastoma. Case reports, literature review, and etiologic considerations , 1986, Cancer.

[142]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[143]  M. Schwab,et al.  Nucleotide sequence of the human N-myc gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[144]  J. Battey,et al.  Human small-cell lung cancers show amplification and expression of the N-myc gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[145]  K. Donaldson,et al.  Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process. , 1986, British journal of experimental pathology.

[146]  R. Storb,et al.  Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience , 1985, Immunological reviews.

[147]  M. Schwab,et al.  Expression of N-myc in teratocarcinoma stem cells and mouse embryos , 1985, Nature.

[148]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[149]  M. Daidone,et al.  Cell kinetics as a prognostic marker in node‐negative breast cancer , 1985, Cancer.

[150]  J. Garson,et al.  N-MYC AMPLIFICATION IN MALIGNANT ASTROCYTOMA , 1985, The Lancet.

[151]  H. Varmus,et al.  Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture , 1985, Nature.

[152]  J Addison,et al.  Inhalation studies on the effects of tremolite and brucite dust in rats. , 1985, Carcinogenesis.

[153]  J. Nagata,et al.  A survey of metrization theory , 1985 .

[154]  W. Tong,et al.  A phase I study of trimetrexate , 1985 .

[155]  M. Israel,et al.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma , 1985, Nature.

[156]  F. Alt,et al.  Activated expression of the N-myc gene in human neuroblastomas and related tumors. , 1984, Science.

[157]  Wen-Hwa Lee,et al.  Expression and amplification of the N-myc gene in primary retinoblastoma , 1984, Nature.

[158]  J. Trent,et al.  Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc , 1984, Nature.

[159]  D. Seckinger,et al.  Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. , 1984, Cancer research.

[160]  M Schwab,et al.  Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[161]  R. Schimke.  Gene amplification in cultured animal cells , 1984, Cell.

[162]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[163]  H. Deeg,et al.  COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE AND METHOTREXATE IN DOGS GIVEN BONE MARROW GRAFTS FROM DLA‐HAPLOIDENTICAL LITTERMATES , 1984, Transplantation.

[164]  I. Webster,et al.  A comparison of the effects of exposure of baboons to crocidolite and fibrous-glass dusts. , 1983, Environmental research.

[165]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[166]  J. Vincent,et al.  An overload hypothesis for pulmonary clearance of UICC amosite fibres inhaled by rats. , 1983, British journal of industrial medicine.

[167]  K. Sullivan,et al.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. , 1983, The New England journal of medicine.

[168]  A. Evans,et al.  Incidence of childhood cancer: experience of a decade in a population-based registry. , 1983, Journal of the National Cancer Institute.

[169]  A. Brody,et al.  Interstitial accumulation of inhaled chrysotile asbestos fibers and consequent formation of microcalcifications. , 1982, The American journal of pathology.

[170]  H. Deeg,et al.  CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE , 1982, Transplantation.

[171]  M. Tatematsu,et al.  NEUROBLASTOMA IN SITU , 1982, Acta pathologica japonica.

[172]  M. Stanton,et al.  Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. , 1981, Journal of the National Cancer Institute.

[173]  C. Osborne,et al.  Epidermal growth factor stimulation of human breast cancer cells in culture. , 1980, Cancer research.

[174]  Jacob Kolner.  ON QUASI-METRIZABILITY , 1980 .

[175]  S. Beckett,et al.  Further observations on the short-term retention and clearance of asbestos by rats, using UICC reference samples. , 1979, The Annals of occupational hygiene.

[176]  J. M. Davis,et al.  Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. , 1978, British Journal of Cancer.

[177]  C. Braestrup,et al.  Benzodiazepine receptors in rat brain , 1977, Nature.

[178]  M. Stanton,et al.  Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. , 1977, Journal of the National Cancer Institute.

[179]  F. Huth,et al.  [Results of animal experiments concerning the carcinogenic effect of fibrous dusts and their interpretation with regard to the carcinogenesis in humans (author's transl)]. , 1976, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe B: Hygiene, praventive Medizin.

[180]  H. Hung.  One more metrization theorem , 1976 .

[181]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[182]  A. Reeves,et al.  Inhalation carcinogenesis from various forms of asbestos. , 1974, Environmental research.

[183]  R. Storb,et al.  RESCUE FROM CANINE GRAFT‐VERSUS-HOST REACTION BY AUTOLOGOUS OR DL‐A-COMPATIBLE MARRO,W , 1974, Transplantation.

[184]  P. Neiman,et al.  Treatment of established human graft-versus-host disease by antithymocyte globulin. , 1974, Blood.

[185]  G. Berry,et al.  The Effects of the Inhalation of Asbestos in Rats , 1974, British Journal of Cancer.

[186]  長田 潤一,et al.  Modern general topology , 1974 .

[187]  R. Hodel.  Some results in metrization theory, 1950–1972 , 1974 .

[188]  R. Storb,et al.  Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone. , 1973, Blood.

[189]  G. Berry,et al.  Mesotheliomata in Rats after Inoculation with Asbestos and Other Materials , 1973, British Journal of Cancer.

[190]  R G Wyatt,et al.  Visualization by Immune Electron Microscopy of a 27-nm Particle Associated with Acute Infectious Nonbacterial Gastroenteritis , 1972, Journal of virology.

[191]  A. Evans,et al.  A proposed staging for children with neuroblastoma. Children's cancer study group A , 1971, Cancer.

[192]  R. Storb,et al.  TREATMENT OF CANINE GRAFT-VERSUS-HOST DISEASE WITH METHOTREXATE AND CYCLOPHOSPHAMIDE FOLLOWING BONE MARROW TRANSPLANTATION FROM HISTOINCOMPATIBLE DONORS , 1970, Transplantation.

[193]  R. Storb,et al.  METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTS , 1970, Transplantation.

[194]  Arindam Banerjee,et al.  Submitted for publication , 1981 .

[195]  J. Beckwith,et al.  IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS. , 1963, The American journal of pathology.

[196]  J. Nagata.  A contribution to the theory of metrization , 1957 .

[197]  A. Pijper.  Tick-Bite Fever. A Clinical Lecture. , 1934 .

[198]  R. Mckernan,et al.  Another mechanism for creating diversity in y-aminobutyrate type A receptors: RNA splicing directs expression of two forms of y2 subunit, one of which contains a protein kinase C phosphorylation site , 2022 .